三级中心收治的心脏骤停复苏存活者毒理学质谱分析
该研究前瞻性纳入单中心186例18-90岁推测心源性心脏骤停复苏患者,收集住院资料并用质谱毒理学检测药物。90%为可电击心律,66%主要病因为缺血性心脏病;82%患者至少检出1种药物(中位2种,IQR 1-4),常见滥用药物16%,延长QT药物12%,多重用药(≥5种)19%,但无一人达到潜在致死浓度。结论认为常规毒理学筛查提供额外信息有限,多重用药在心脏骤停中的作用需进一步研究。
要点
- 186例推测心源性心脏骤停复苏患者中,82%至少检出1种药物,中位2种(IQR 1-4)。
- 常见滥用药物检出率16%,延长QT药物12%,多重用药(≥5种)19%。
- 无患者检出潜在致死浓度的药物,未发现隐匿性药物过量所致心脏骤停。
- 90%为可电击心律,66%主要病因为缺血性心脏病。
- 作者认为常规毒理学筛查提供额外信息有限,多重用药的作用需进一步研究。
适用人群与场景
- 18-90岁推测心源性心脏骤停复苏患者,前瞻性纳入自单中心三级中心。
研究设计与关键结果
- 前瞻性单中心研究,连续纳入186例复苏后心脏骤停患者,中位年龄62岁,83%男性,90%为可电击心律,66%主要病因为缺血性心脏病。
- 共鉴定90种不同药物(不含代谢物),82%患者至少检出1种药物,中位检出2种(IQR 1-4)。
- 常见滥用药物存在于16%患者,延长QT药物存在于12%患者,多重用药(≥5种)见于19%患者。
- 无患者检出任何药物的潜在致死浓度,未发现隐匿性药物过量相关心脏骤停。
证据类型、等级与局限
- 证据类型:前瞻性单中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对推测心源性心脏骤停复苏患者,常规毒理学筛查提供额外信息有限。
- 作者认为,多重用药在心脏骤停中的作用需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There has been no previous thorough toxicological examination of a cohort of patients with resuscitated sudden cardiac arrest. We aimed to determine the qualitative and quantitative drug composition in a resuscitated sudden cardiac arrest population, using forensic toxicology, with focus on prescribed, non-prescribed, and commonly abused drugs.
METHODS: Individuals aged 18-90 years with resuscitated sudden cardiac arrest of presumed cardiac causes were prospectively included from a single tertiary center. Data from the sudden cardiac arrest hospitalization was collected from medical reports. Drugs used during resuscitation or before the blood sampling were identified and excluded in each patient. Mass spectrometry-based toxicology was performed to determine the absence or presence of most drugs and to quantify the findings.
RESULTS: Among 186 consecutively enrolled resuscitated sudden cardiac arrest patients (median age 62 years, 83% male), 90% had a shockable rhythm, and were primarily caused by ischemic heart disease (66%). In total, 90 different drugs (excluding metabolites) were identified, and 82% of patients had at least one drug detected (median of 2 detected drugs (IQR:1-4)) (polypharmacy). Commonly abused drugs were present in 16%, and QT-prolonging drugs were present in 12%. Polypharmacy (≥5drugs) were found in 19% of patients. Importantly, none had potentially lethal concentrations of any drugs.
CONCLUSION: In resuscitated sudden cardiac arrest patients with cardiac arrest of presumed cardiac cause, routine toxicological screening provides limited extra information. However, the role of polypharmacy in sudden cardiac arrest requires further investigation. No occult overdose-related cardiac arrests were identified.
参考来源
- Stampe NK, Glinge C, Rasmussen BS, et al. Toxicological profile using mass spectrometry in sudden cardiac arrest survivors admitted to a tertiary centre. Resuscitation. 2024. PMID: 38582441. doi:10.1016/j.resuscitation.2024.110197
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。